Chinese biotech censured for misleading coronavirus drug claimsChina’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able Share XChinese biotech censured for misleading coronavirus drug claimshttps://pharmaphorum.com/news/chinese-biotech-censured-for-misleading-coronavirus-drug-claims/